Adpt stock nasdaq
23 Jan 2020 SEATTLE, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology 12 Mar 2020 bought a fresh place in Adaptive Biotechnologies Corporation (NASDAQ:ADPT). The institutional investor bought 1.5 million shares of the stock